Rimactane and cytolytic hepatitis Patient Reports February 12, 2012

Rimactane Side Effects Report #4699422-3
Rimactane side effect was reported by a Consumer or non-health professional from on June 10, 2005. Male patient, 87 years of age, was diagnosed with streptococcal infection  and was treated with Rimactane. After drug was administered, patient experienced the following side effects: cytolytic hepatitis, haemoglobin decreased, hepatitis cholestatic, lymphopenia, platelet count increased. Rimactane dosage: 1800 MG, QD, ORAL. During the same period patient was treated with CLAMOXYL, OMEPRAZOLE, GLYBURIDE, ACETAMINOPHEN, OMIX. Patient was hospitalized. Patient recovered.

Rimactane Side Effects Report #4562145-5
Rimactane side effect was reported by a Consumer or non-health professional from on Jan 10, 2005. Male patient, 87 years of age, was treated with Rimactane. After drug was administered, patient experienced the following side effects: cytolytic hepatitis, hepatic enzyme increased, hepatitis cholestatic, lymphopenia, pruritus. Rimactane dosage: 1800 MG, QD, ORAL. During the same period patient was treated with OMEPRAZOLE, GLYBURIDE, ACETAMINOPHEN, OMIX, CLAMOXYL. Patient was hospitalized. Patient recovered.

Rimactane Side Effects Report #5716169-2
Rimactane side effect was reported by a Physician from SWITZERLAND on Apr 10, 2008. Female patient, 55 years of age, weighting 176.4 lb, was diagnosed with bladder cancer , urinary tract infection  and was treated with Rimactane. After drug was administered, patient experienced the following side effects: bovine tuberculosis, bronchial hyperreactivity, cholestasis, condition aggravated, cytolytic hepatitis, liver injury, lung neoplasm, sepsis . Rimactane dosage: 600 MG, QD, ORAL. During the same period patient was treated with IMMUCYST, ROCEPHIN, RIMIFON, SIMCORA, PREDNISONE. Patient was hospitalized. Patient recovered.